China NASH Biomarkers Market: Addressing the Growing Burden of...

добавлена новая статья Saúde & Bem Estar

2026-10-05 06:02:23 -

China NASH Biomarkers Market: Addressing the Growing Burden of Liver Disease

The China Non Alcoholic Steatohepatitis Biomarkers Market was valued at USD 7.5 million in 2024 and is projected to grow to USD 96.92 million by 2035, registering a CAGR of 26.19% during the forecast period. This remarkable growth trajectory reflects the essential role of NASH biomarkers in addressing the demand for effective diagnostic solutions, improved patient outcomes, and innovative liver...

0 Комментарии 0 Поделились 0 предпросмотр